| Status | Study |
| Recruiting |
Study Name: Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Date: 2016-01-14 Interventions: Drug: Cytarabine Given IV |
| Recruiting |
Study Name: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Date: 2014-03-11 Interventions: Drug: clofarabine Given IV |
| Recruiting |
Study Name: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Date: 2014-02-24 Interventions: Drug: eltrombopag olamine Given PO Other Names: |
| Terminated |
Study Name: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Date: 2014-01-06 Interventions: Drug: cytarabine Given SC |
| Active, not recruiting |
Study Name: Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Date: 2012-10-08 Interventions: Drug: decitabine Given IV |
| Withdrawn |
Study Name: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia Date: 2012-07-20 Interventions: Drug: cyclophosphamide Given I |
| Completed |
Study Name: Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Adult Acute Date: 2012-03-28 Interventions: Drug: tosedostat Given PO |
| Terminated |
Study Name: Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Date: 2011-10-10 Interventions: Drug: bortezomib Given SC Other Names: |
| Completed |
Study Name: Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Date: 2011-05-06 Interventions: Drug: alvocidib Given IV |
| Completed |
Study Name: Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk Date: 2010-11-04 Interventions: Procedure: standard follow-up care |